Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

46.70USD
20 Jul 2018
Change (% chg)

$-0.24 (-0.51%)
Prev Close
$46.94
Open
$47.00
Day's High
$47.39
Day's Low
$46.60
Volume
5,917
Avg. Vol
9,027
52-wk High
$53.33
52-wk Low
$38.12

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.49
Market Cap(Mil.): $336.18
Shares Outstanding(Mil.): 7.21
Dividend: --
Yield (%): --

Financials

  BSTC.OQ Industry Sector
P/E (TTM): 26.28 214.53 33.05
EPS (TTM): 1.79 -- --
ROI: 17.71 -3.67 13.17
ROE: 18.46 -5.61 15.10

BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54

* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Biospecifics Technologies Q4 Earnings Per Share $0.36

* . REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 14 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $125.85 -0.09
Novartis AG (NOVN.S) CHF82.20 +1.24
Pfizer Inc. (PFE.N) $37.33 -0.03
Roche Holding Ltd. (ROG.S) CHF234.00 +2.05
Roche Holding Ltd. (RO.S) CHF238.60 +2.80
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Bayer AG (BAYGn.DE) €92.05 -0.30
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.36 +0.25
GlaxoSmithKline plc (GSK.L) 1,549.80 -8.20

Earnings vs. Estimates